|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Research and development tax credit receivable | ||||||||||||||||||||
| Other tax receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total prepaid expenses – related party | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Equipment, net | ||||||||||||||||||||
| Operating lease – right of use asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Acquired in-process research and development intangible assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities – related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable and accrued liabilities – related parties | ||||||||||||||||||||
| Deferred liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current portion of long-term debt, net | ||||||||||||||||||||
| Operating lease, current liabilities | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term operating lease liability | ||||||||||||||||||||
| Accrued liability – long-term | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Redeemable common stock, $0.001 par value; 0 and 75,697 shares issued and outstanding, respectively (Note 9) | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, $0.001 par value, 200,000,000 shares authorized, 27,653,789 and 26,585,258 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
